Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 29, 2021

SELL
$35.91 - $40.68 $1.72 Million - $1.95 Million
-47,922 Closed
0 $0
Q1 2021

May 20, 2021

BUY
$33.49 - $37.77 $25,988 - $29,309
776 Added 1.65%
47,922 $1.76 Million
Q1 2021

May 05, 2021

SELL
$33.49 - $37.77 $171,033 - $192,891
-5,107 Reduced 9.77%
47,146 $1.71 Million
Q4 2020

Feb 11, 2021

SELL
$33.47 - $42.56 $86,519 - $110,017
-2,585 Reduced 4.71%
52,253 $1.92 Million
Q3 2020

Nov 04, 2020

SELL
$31.75 - $37.25 $60,229 - $70,663
-1,897 Reduced 3.34%
54,838 $2.01 Million
Q2 2020

Aug 10, 2020

BUY
$30.12 - $36.54 $23,945 - $29,049
795 Added 1.42%
56,735 $1.86 Million
Q1 2020

May 12, 2020

SELL
$27.03 - $38.62 $41,896 - $59,860
-1,550 Reduced 2.7%
55,940 $1.83 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $2,864 - $3,250
-87 Reduced 0.15%
57,490 $2.25 Million
Q3 2019

Nov 07, 2019

SELL
$32.49 - $42.13 $96,462 - $125,083
-2,969 Reduced 4.9%
57,577 $2.07 Million
Q2 2019

Aug 01, 2019

BUY
$36.98 - $41.52 $2,810 - $3,155
76 Added 0.13%
60,546 $2.62 Million
Q1 2019

May 16, 2019

BUY
$37.5 - $41.2 $33,450 - $36,750
892 Added 1.5%
60,470 $2.57 Million
Q4 2018

Jan 30, 2019

SELL
$38.47 - $43.86 $52,588 - $59,956
-1,367 Reduced 2.24%
59,578 $2.6 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $31,367 - $38,047
910 Added 1.52%
60,945 $2.69 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $43,632 - $46,516
-1,323 Reduced 2.16%
60,035 $2.18 Million
Q1 2018

May 11, 2018

BUY
$31.91 - $37.02 $58,937 - $68,375
1,847 Added 3.1%
61,358 $2.18 Million
Q4 2017

Feb 15, 2018

BUY
$33.26 - $35.29 $1.98 Million - $2.1 Million
59,511
59,511 $2.16 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Slow Capital, Inc. Portfolio

Follow Slow Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Slow Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Slow Capital, Inc. with notifications on news.